Shorts losing control as $SGMO stock confirm golden cross 50/200
Following on strong momentum after Novartis deal, Sangamo Therapeutics with strong open that looks set to breakout the stock from a long sustained downtrend
Trade active
Stay long, sgmo never breached below critical 9.4 support in my chart from august
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.